Melphalan-total body irradiation and autologous bone marrow transplantation for adult acute leukemia beyond first remission

Bone Marrow Transplantation

Volumn 18, Issue 1, 1996, Pages 119-123

  Mehta, J ^a   Powles, R ^a   Singhal, S ^a   Horton, C ^a   Tait, D ^a   Treleaven, J ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Acute lymphoblastic leukemia; Acute myeloid leukemia; Autologous bone marrow transplantation; Melphalan; Peripheral blood stem cell transplantation; Remission inversion; Total body irradiation

Indexed keywords

MELPHALAN; MERCAPTOPURINE; METHOTREXATE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW PURGING; CANCER MORTALITY; CANCER REGRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NEUTROPHIL; PRIORITY JOURNAL; RELAPSE; SURVIVAL TIME; THROMBOCYTE COUNT; WHOLE BODY RADIATION;

6-MERCAPTOPURINE; ACUTE DISEASE; ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW PURGING; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOID; MALE; MELPHALAN; METHOTREXATE; MIDDLE AGED; PROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION;

EID: 0029775179     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Rosenfeld C, Shadduck RK, Przepiorka D et al. Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for acute nonlymphocytic leukemia in late remission or early relapse. Blood 1989; 74: 1159-1164.
2. Yeager AM, Rowley SD, Kaizer H, Santos GW. Ex vivo chemopurging of autologous bone marrow with 4-hydroperoxycyclophosphamide to eliminate occult leukemic cells. Laboratory and clinical observations. Am J Pediatr Hematol Oncol 1990; 12: 245-256.
3. Colleselli P, Dini G, Andolina M et al. Autologous bone marrow transplantation for acute lymphoblastic leukemia: the high dose vincristine study of AIEOP BMT group. Bone Marrow Transplant 1991; 7 (Suppl. 3): 28-30.
4. Soiffer RJ, Roy DC, Gonin R et al. Monoclonal antibodypurged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse. Bone Marrow Transplant 1993; 12: 243-251.
5. Doney K, Buckner CD, Fisher L et al. Autologous bone marrow transplantation for acute lymphoblastic leukemia. Bone Marrow Transplant 1993; 12: 315-321.
6. Selvaggi KJ, Wilson JW, Mills LE et al. Improved outcome for high-risk acute myeloid leukemia patients using autologous bone marrow transplantation and monoclonal antibodypurged bone marrow. Blood 1994; 83: 1698-1705.
7. Laporte JP, Douay L, Lopez M et al. One hundred twenty-five adult patients with primary acute leukemia autografted with marrow purged by mafosfamide: a 10-year single institution experience. Blood 1994; 84: 3810-3818.
8. Lenarsky C, Weinberg K, Petersen J et al. Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for children with acute non-lymphoblastic leukemia in second remission. Bone Marrow Transplant 1990; 6: 425-429.
9. Chopra R, Goldstone AH, McMillan AK et al. Successful treatment of acute myeloid leukemia beyond first remission with autologous bone marrow transplantation using busulfan/cyclophosphamide and unpurged marrow: the British autograft group experience. J Clin Oncol 1991; 9: 1840-1847.
10. Petersen FB, Lynch MHE, Clift RA et al. Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission. J Clin Oncol 1993; 11: 1353-1360.
11. Schmid H, Henze G, Schwerdtfeger R et al. Fractionated total body irradiation and high-dose VP-16 with purged autologous bone marrow rescue for children with high risk relapsed acute lymphoblastic leukemia. Bone Marrow Transplant 1993; 12: 597-602.
12. Meloni G, De Fabritiis P, Petti MC, Mandelli F. BAVC regimen and autologous bone marrow transplantation in patients with acute myelogenous leukemia in second remission. Blood 1990; 75: 2282-2285.
13. Schroeder H, Pinkerton CR, Powles RL et al. High dose melphalan and total body irradiation with autologous marrow rescue in childhood acute lymphoblastic leukaemia after relapse. Bone Marrow Transplant 1991; 7: 11-15.
14. Linker CA, Ries CA, Damon LE et al. Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as a preparative regimen. Blood 1993; 81: 311-318.
15. Billett AL, Kornmehl E, Tarbell NJ et al. Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia. Blood 1993; 81: 1651-1657.
16. Powles R, Mehta J, Singhal S et al. Autologous bone marrow or peripheral blood stem cell transplantation followed by maintenance chemotherapy for adult acute lymphoblastic leukemia in first remission: 50 cases from a single center. Bone Marrow Transplant 1995; 16: 241-247.
17. Mehta J, Powles R, Singhal S et al. Autologous bone marrow transplantation for acute myeloid leukemia in first remission: identification of modifiable prognostic factors. Bone Marrow Transplant 1995; 16: 499-506.
18. Powles R, Milan S, Horton C et al. A prospective haematooncology patient database: structure and description. Bone Marrow Transplant 1996; 17 (Suppl. 1): S140.
19. Powles R, Milan S, Horton C et al. A prospective haematooncology patient database for use in routine care and clinical research. Bone Marrow Transplant 1996; 17 (Suppl. 1): S55.
20. Mehta J, Powles R, Singhal S, Treleaven J. Peripheral blood stem cell transplantation may result in increased relapse of acute myeloid leukaemia due to reinfusion of a higher number of malignant cells. Bone Marrow Transplant 1995; 15: 652-653.
21. Mehta J, Powles R, Singhal S et al. Peripheral blood stem cell autografts for acute lymphoblastic leukemia: effect of G-CSF dose and harvest schedule on cell yields. Br J Haematol 1995; 89 (Suppl. 1): 19.
22. Tiley C, Powles R, Treleaven J et al. Feasibility and efficacy of maintenance chemotherapy following autologous bone marrow transplantation for first remission acute lymphoblastic leukaemia. Bone Marrow Transplant 1993; 12: 449-455.
23. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
24. Peto R, Pike MC, Armitage P et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1-39.
25. Allieri MA, Lopez M, Douay L et al. Clonogenic leukemic progenitor cells in acute myelocytic leukemia are highly sensitive to cryopreservation: possible purging effect for autologous bone marrow transplantation. Bone Marrow Transplant 1991; 7: 101-105.
26. Schiffman K, Clift R, Appelbaum FR et al. Consequences of cryopreserving first remission autologous marrow for use after relapse in patients with acute myeloid leukemia. Bone Marrow Transplant 1993; 11: 227-232.
27. Talbot DC, Powles RL, Sloane JP et al. Cyclosporine-induced graft-versus-host disease following autologous bone marrow transplantation in acute myeloid leukaemia. Bone Marrow Transplant 1990; 6: 17-20.
28. Nagler A, Ackerstein A, Or R et al. Adoptive immunotherapy with mismatched allogeneic peripheral blood lymphocytes (PBL) following autologous bone marrow transplantation (ABMT). Exp Hematol 1992; 20: 705.
29. Slavin S, Or R, Kapelushnik Y et al. Immunotherapy of minimal residual disease in conjunction with autologous and allogeneic bone marrow transplantation (BMT), Leukemia 1992; 6 (Suppl. 4): 164-166.
30. Benyunes MC, Massumoto C, York A et al. Interleukin-2 with or without lymphokine-activated killer cells as consolidative immunotherapy after autologous bone marrow transplantation for acute myelogenous leukemia. Bone Marrow Transplant 1993; 12: 159-163.